Featured Articles

  MRI   Translational Research for Interventional Magnetic Resonance Imaging and Magnetic Resonance Visualisation of Vascular Implants
Andreas Melzer Director, Institute for Medical Science and Technology, Universities of Dundee and St Andrews
The new Dundee Clinical Research Centre (CRC) is a joint activity of the College of Medicine and NHS Tayside Ninewells Hospital and Medical School – one of the largest teaching hospitals in Europe.
 
         
  signal  

Safety Aspects in Carotid Artery Stenting - Is Flow Reversal the Solution?
Johan Formgren Head of Peripheral Vascular Interventions, Department of Medical Imaging, Södersjukhuset AB, Stockholm
Since the publication of the Endarterectomy versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) and Stent-supported Percutaneous Angioplasty of the Carotid Artery versus Endarterectomy (SPACE) studies, doubts have been raised regarding the safety of CAS as an alternative carotid intervention to CEA.

 
         
  Skylor stent
  LEONARDO - Clinical Evaluation of a Last Generation Coronary Stent in a Real World Typical Non-DES Population - A Prospective, Single-centre Registry
Jacques J Koolen and Maria Rosaria De Vita, Catharina Hospital, The Netherlands and Policlinico Gemelli Universita Cattolica Sacro Cuore, Italy
While rates of restenosis and MACEs have both been demonstrated to be significantly reduced with the use of drugeluting stents (DES) compared with BMS in a broad variety of trials,1–6 the same trials could not demonstrate any difference in mortality or AMI rates.
 


Three-dimensional Echocardiography in Mitral Valve Disease
Cardiology
The Society for Cardiac Angiography and Interventions American Heart Association  Heart Online    Association of British Medical Journals   TCTMD
Cardiology » Articles » Three-dimensional Echocardiography in Mitral Valve Disease
Wednesday, 23 July, 2008



Three-dimensional Echocardiography in Mitral Valve Disease

Dr Otto Kamp Director of Echocardiography, VU University Medical Centre of Amsterdam

  Previous     1    2    3    4   5    Next  

Mitral Annular Geometry

Flachskampf et al. and Kaplan et al. have shown that functional mitral regurgitation is associated with annular dilation and its reduced cyclic variation by using 3-D echocardiography.(5,6) Compared with normal subjects, the annulus in patients with functional mitral regurgitation is larger and has greater mitral annular area, longer perimeter, reduced annular height and eccentricity and increased distance between high points of the mitral annulus.

Leaflet Geometry

Using RT3D echocardiography, Kwan et al. studied the difference of mitral valve deformation between ischaemic and dilated cardiomyopathy with significant functional mitral regurgitation.(40) Mitral valve tethering has been found to be the strongest determinant of mitral regurgitation severity and the pattern of mitral valve deformation was asymmetrical in ischaemic heart disease, whereas it was symmetrical in dilated cardiomyopathy

Papillary Muscle Geometry

Several studies have been performed in an effort to elucidate a 3-D papillary muscle–mitral relationship.(41–44) The results of these studies show that medial and posterior shift of the ischaemic medial papillary muscle, measured by 3-D reconstruction, is particularly related to the development of functional mitral regurgitation.

Mitral Valve Repair and 3-D Echocardiography

Mitral valve repair has become more common in the last decade, accounting for half of the mitral valve procedures.(45) Various techniques have been proposed for valve reconstructions.(46–48) The decision of ‘how to operate’ depends on the underlying pathology of the mitral valve diagnosed by pre-operative echocardiography. Conventional 2-D echocardiography is a useful guide for accurate surgical analysis; however, in complex valvular pathologies some spatial relations and different structural features can be perceived erroneously even by experienced echocardiographers. The technique of repair is consistently modified in the operating room by close examination of the mitral valve, although the surgeon is challenged by limited time, operating field and non-physiological condition of the heart being devoid of blood. 3-D echocardiography has the potential to overcome these difficulties by showing the heart in the ‘surgeon’s view’ and even in a more physiological state as in operation.

There are few published data regarding the feasibility of 3-D echocardiography in the operating theatre. Abraham et al. demonstrated that, in 25% of cases, 3-D echocardiography can detect new morphologic findings (mainly valve fenestrations) not seen with 2-D TOE. In one patient, 3-D TOE resulted in a decision to perform valve repair instead of replacement. As previously mentioned, 3-D TOE has been proven as accurate in identifying the location of the prolapsing segment and quantifying the amount of the prolapsed tissue by measuring the area or the width. This information could aid the surgeon in deciding the extent of mitral valve resection.

Conclusion

3-D echocardiography allows visualisation of the heart differently to 2-D echocardiography, as it looks at the heart in true reality. The assessment of the morphology, function and pathology of the heart, and particularly the mitral valve apparatus by 3-D echocardiography, becomes more accurate. Compared with 2-D echocardiography, 3-D echocardiography offers advantages for the morphologic and quantitative assessment of mitral valve stenosis, prolapse and regurgitation. It appears that 3-D echocardiography has the potential for planning operations and assessing interventional or surgical results. Furthermore, 3-D echocardiography provides new quantitative indices unobtainable by conventional 2-D imaging. Both technical improvement and larger studies will enhance the clinical applicability of 3-D echocardiography in the near l'efuture.

  Previous     1    2    3    4   5    Next  

Keywords and Categories
Category:



Author(s) Biography
Dr Otto Kamp is Associate Professor of Cardiology and Director of Echocardiography at the VU University Medical Centre of Amsterdam. He was previously a consultant in the Department of Cardiology at the Academic Hospital Rotterdam. He is a member of the Working Group of Echocardiography of the European Society of Cardiology (ESC), a board member of the Dutch Working Group of Echocardiology and project leader at the Inter Cardiology Institute of the Netherlands (ICIN) and is principal investigator in multiple clinical trials. He also sits of the editorial board of several scientific journals and is a reviewer for numerous others. Dr Kamp gained a PhD from the VU Medical Centre of Amsterdam in 1992.

Send Article Feedback
Title*:

Comment*:

Name*:
Email Address*:
Location*:

Add me to mailing list

I Agree to terms and conditions


Order Reprint


Order high-quality repints of any
articles on this website


Instructions for Authors
Instructions for authors, click here for details

Submit an Article
Submit an article, click here for details

  Copyright Touch Briefings 2005 - 2008    Promotional Opportunities | Terms & Conditions | Privacy Statement|

Articles : a b c d e f g h i j k l m n o p q r s t u v w x y z
Companies : a b c d e f g h i j k l m n o p q r s t u v w x y z
Events : a b c d e f g h i j k l m n o p q r s t u v w x y z
Keywords : a b c d e f g h i j k l m n o p q r s t u v w x y z

Specialities :

Arrhythmia Cardiac Imaging Congenital Heart Disease Coronary Artery Disease Heart Disease Prevention Heart Failure Hyperlipidemia Hypertension Interventional Cardiology Pediatric Cardiology Peripheral Artery Disease

Other Touch Group sites:   

Neurology - Endocrine Disease - Oncological Disease - Gastroenterology - Respiratory Disease